
|Articles|February 5, 2008
New label approved to reflect Thrombin-JMI manufacturing changes
FDA approves revised labeling for Thrombin-JMI.
Advertisement
Enhanced processes to reduce Factor V light chain content to undetectable levels during the manufacture of
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
2
Community Pharmacies Need to Better Prioritize Whole-Person Health Care | NCPA 2025
3
American Pharmacists Month: Pharmacist Barriers, Expansion of Scope Since the COVID-19 Pandemic
4
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
5


























































































































































